Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Engelman

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
The Lancet Regional Health. Western Pacific|February 15, 2024
Effectiveness of one and two doses of ivermectin mass drug administration in reducing the prevalence and intensity of soil-transmitted helminth (STH) infections in Western Province, Solomon Islands: a cluster-randomised, before-after analysisBrandon Le, Naomi E Clarke, Sze Fui Hii, et al.
Parasites & Vectors|March 16, 2021
Prevalence of scabies and impetigo in school-age children in Timor-LesteAlexander Matthews, Brandon Le, Salvador Amaral, et al.
Circulation|June 12, 2023
Refining Risk Stratification Among Children With Latent Rheumatic Heart DiseaseAndrea Beaton, Emmy Okello, Joselyn Rwebembera, et al.
Plos Neglected Tropical Diseases|September 2, 2021
A framework for scabies controlDaniel Engelman, Michael Marks, Andrew C Steer, et al.
The New England Journal of Medicine|November 12, 2021
Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart DiseaseAndrea Beaton, Emmy Okello, Joselyn Rwebembera, et al.
Circulation|September 15, 2025
Short-Course Secondary Antibiotic Prophylaxis for Children With Screen-Detected Mild Rheumatic Heart DiseaseJoselyn Rwebembera, Craig Sable, Anneke C Grobler, et al.
The Lancet. Microbe|November 22, 2025
Direct and indirect protection against scabies through ivermectin mass drug administration designed for malaria in Mozambique: a substudy nested within a cluster-randomised, controlled trialJoanna Furnival-Adams, Amelia Houana, Francisco Saute, et al.
Journal of the American Heart Association|January 14, 2026
With Antibiotic Prophylaxis, Mild Rheumatic Heart Disease Rarely Progresses Over 5 YearsJoselyn Rwebembera, Craig Sable, Anneke C Grobler, et al.
Lancet (London, England)|June 11, 2019
The public health control of scabies: priorities for research and actionDaniel Engelman, Paul T Cantey, Michael Marks, et al.
ESC Heart Failure|June 13, 2026
Machine Learning Based Prediction of Hospital Mortality in Post-Cardiotomy Cardiogenic Shock with Mechanical SupportAhmad Mahajna, Michal Kawczynski, Silvia Mariani, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
The Lancet Regional Health. Western Pacific|February 15, 2024
Effectiveness of one and two doses of ivermectin mass drug administration in reducing the prevalence and intensity of soil-transmitted helminth (STH) infections in Western Province, Solomon Islands: a cluster-randomised, before-after analysisBrandon Le, Naomi E Clarke, Sze Fui Hii, et al.
Parasites & Vectors|March 16, 2021
Prevalence of scabies and impetigo in school-age children in Timor-LesteAlexander Matthews, Brandon Le, Salvador Amaral, et al.
Circulation|June 12, 2023
Refining Risk Stratification Among Children With Latent Rheumatic Heart DiseaseAndrea Beaton, Emmy Okello, Joselyn Rwebembera, et al.
Plos Neglected Tropical Diseases|September 2, 2021
A framework for scabies controlDaniel Engelman, Michael Marks, Andrew C Steer, et al.
The New England Journal of Medicine|November 12, 2021
Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart DiseaseAndrea Beaton, Emmy Okello, Joselyn Rwebembera, et al.
Circulation|September 15, 2025
Short-Course Secondary Antibiotic Prophylaxis for Children With Screen-Detected Mild Rheumatic Heart DiseaseJoselyn Rwebembera, Craig Sable, Anneke C Grobler, et al.
The Lancet. Microbe|November 22, 2025
Direct and indirect protection against scabies through ivermectin mass drug administration designed for malaria in Mozambique: a substudy nested within a cluster-randomised, controlled trialJoanna Furnival-Adams, Amelia Houana, Francisco Saute, et al.
Journal of the American Heart Association|January 14, 2026
With Antibiotic Prophylaxis, Mild Rheumatic Heart Disease Rarely Progresses Over 5 YearsJoselyn Rwebembera, Craig Sable, Anneke C Grobler, et al.
Lancet (London, England)|June 11, 2019
The public health control of scabies: priorities for research and actionDaniel Engelman, Paul T Cantey, Michael Marks, et al.
ESC Heart Failure|June 13, 2026
Machine Learning Based Prediction of Hospital Mortality in Post-Cardiotomy Cardiogenic Shock with Mechanical SupportAhmad Mahajna, Michal Kawczynski, Silvia Mariani, et al.
Pageof 10